APA (7th ed.) Citation

Wetzel, E., Nohman, A., Hsieh, A. L., Reuss, D., Unterberg, A., Eyüpoglu, I. Y., . . . Miller, J. J. (2024). A multi-center, clinical analysis of IDH-mutant gliomas, WHO Grade 4: Implications for prognosis and clinical trial design. Journal of neuro-oncology, 171(2), . https://doi.org/10.1007/s11060-024-04852-7

Chicago Style (17th ed.) Citation

Wetzel, Ethan, et al. "A Multi-center, Clinical Analysis of IDH-mutant Gliomas, WHO Grade 4: Implications for Prognosis and Clinical Trial Design." Journal of Neuro-oncology 171, no. 2 (2024). https://doi.org/10.1007/s11060-024-04852-7.

MLA (9th ed.) Citation

Wetzel, Ethan, et al. "A Multi-center, Clinical Analysis of IDH-mutant Gliomas, WHO Grade 4: Implications for Prognosis and Clinical Trial Design." Journal of Neuro-oncology, vol. 171, no. 2, 2024, https://doi.org/10.1007/s11060-024-04852-7.